Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery
New Category Will Introduce a Closed-Loop Framework: Predict. Perform. Recover. Keeping the Surgeon's Expertise and Control at the Center of the OR DALLAS, Nov. 6, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today will announce Surgeon-Guided Autonomy, a new...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 115 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.